webinar series
After participating in this webinar, learners will be able to:
· Describe the core principles and objectives of cardio-oncology and its role in optimizing cardiovascular care across the cancer continuum.
· Review current evidence and clinical updates related to the prevention and management of adverse cardiovascular outcomes during and after Hodgkin lymphoma treatment.
· Identify the cardiovascular risks, including atrial fibrillation, associated with Bruton’s tyrosine kinase inhibitor (BTKi) therapy and discuss appropriate monitoring strategies.
· Apply case-based approaches to cardiovascular risk stratification and management in patients receiving contemporary cancer therapies.
· Integrate multidisciplinary perspectives to improve cardiovascular outcomes and long-term quality of life for people with cancer.
This webinar is intended for cardiologists, oncologists, haematologists, general practitioners, pharmacists, nurses, and allied healthcare professionals involved in the care of patients with cancer or cancer survivors, particularly those managing cardiovascular risk before, during, or after oncologic treatment.

restricted content
Access to the e-Learning and Experts sections is available to ISCP Members only. Already a Member? Log in Not yet a Member? Visit our Registration page for details of how to join the ISCP and learn more about the benefits of being a part.
Stay updated
Sign up to receive news and updates on our iniciatives, content and events.